[go: up one dir, main page]

MX2016002932A - Biomarcadores para determinacion temprana de una respueta critica o que pone la vida en peligro a la enfermedad y/o en respuesta al tratamiento. - Google Patents

Biomarcadores para determinacion temprana de una respueta critica o que pone la vida en peligro a la enfermedad y/o en respuesta al tratamiento.

Info

Publication number
MX2016002932A
MX2016002932A MX2016002932A MX2016002932A MX2016002932A MX 2016002932 A MX2016002932 A MX 2016002932A MX 2016002932 A MX2016002932 A MX 2016002932A MX 2016002932 A MX2016002932 A MX 2016002932A MX 2016002932 A MX2016002932 A MX 2016002932A
Authority
MX
Mexico
Prior art keywords
illness
biomarkers
critical
response
life threatening
Prior art date
Application number
MX2016002932A
Other languages
English (en)
Inventor
Kain Kevin
Conrad Liles W
Erdman Laura
Conroy Andrea
Original Assignee
Fio Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fio Corp filed Critical Fio Corp
Priority claimed from PCT/CA2014/050841 external-priority patent/WO2015031996A1/en
Publication of MX2016002932A publication Critical patent/MX2016002932A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La invención se refiere al uso de biomarcadores novedosos y combinaciones de biomarcadores que tienen utilidad en la determinación temprana de la respuesta crítica y/o que pone la vida en peligro de un individuo a la enfermedad y/o en predecir el resultado de la enfermedad. La medición de los niveles de expresión de los productos de los biomarcadores y combinaciones de biomarcadores de la invención tiene utilidad en hacer la determinación de la respuesta crítica y/o que ponen la vida en peligro de un individuo a la enfermedad. En algunas modalidades, el biomarcador y combinaciones de biomarcadores son agnósticos y son independientes de la pre-identificación y/o determinación de la causa o naturaleza de la enfermedad. En algunas modalidades, los biomarcadores y combinaciones de biomarcadores se pueden utilizar para seleccionar el tratamiento y/o monitorear la efectividad de las intervenciones de tratamiento para un individuo quien tiene una enfermedad crítica.
MX2016002932A 2012-02-27 2014-09-05 Biomarcadores para determinacion temprana de una respueta critica o que pone la vida en peligro a la enfermedad y/o en respuesta al tratamiento. MX2016002932A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261603765P 2012-02-27 2012-02-27
US14/019,447 US20140179806A1 (en) 2012-02-27 2013-09-05 Biomarkers for early determination of a critical or life threatening response to illness and/or treatment response
PCT/CA2014/050841 WO2015031996A1 (en) 2013-09-05 2014-09-05 Biomarkers for early determination of a critical or life threatening response to illness and/or treatment response

Publications (1)

Publication Number Publication Date
MX2016002932A true MX2016002932A (es) 2017-02-02

Family

ID=49081491

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016002932A MX2016002932A (es) 2012-02-27 2014-09-05 Biomarcadores para determinacion temprana de una respueta critica o que pone la vida en peligro a la enfermedad y/o en respuesta al tratamiento.

Country Status (5)

Country Link
US (1) US20140179806A1 (es)
EP (1) EP2820427A4 (es)
CA (2) CA2957365A1 (es)
MX (1) MX2016002932A (es)
WO (1) WO2013127000A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014407088B2 (en) 2014-09-26 2021-09-23 Somalogic Operating Co., Inc. Cardiovascular risk event prediction and uses thereof
US10851418B2 (en) 2015-01-12 2020-12-01 The George Washington University A Congressional Chartered Not-For-Profit Corporation Blood biomarkers for respiratory infections
JP2023536494A (ja) * 2020-08-03 2023-08-25 ジェンフィット Ｎａｓｈリスク評価の方法
CN114441764B (zh) * 2021-12-24 2022-09-27 广州市妇女儿童医疗中心 Angiogenin作为先天性巨结肠肠炎早期预测及诊断标志物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009059404A1 (en) * 2007-11-05 2009-05-14 University Health Network Angiopoietin-1 and -2 biomarkers for infectious diseases that compromise endothelial integrity
BRPI1009276A2 (pt) * 2009-03-02 2016-03-08 Fio Corp painel, kit, dispositivo, método e meio legível por computador para teste diagnóstico rápido para uso na diagnose de malária e infecção bacteriana grave numa amostra de teste
US8367350B2 (en) * 2009-04-29 2013-02-05 Morehouse School Of Medicine Compositions and methods for diagnosis, prognosis and management of malaria
WO2012016333A1 (en) * 2010-08-06 2012-02-09 University Health Network Biomarkers for malaria

Also Published As

Publication number Publication date
US20140179806A1 (en) 2014-06-26
EP2820427A1 (en) 2015-01-07
CA2879214A1 (en) 2013-09-06
CA2957365A1 (en) 2013-09-06
WO2013127000A1 (en) 2013-09-06
EP2820427A4 (en) 2015-12-02

Similar Documents

Publication Publication Date Title
BR112016004963A2 (pt) biomarcadores para determinação precoce de uma resposta crítica ou de risco de vida para resposta de tratamento e/ou doença
MD20130098A2 (ro) Test pentru determinarea lizil oxidazei-2 şi metode de utilizare a acestuia
BR112013006683A2 (pt) diagnóstico de câncer de mama
MX2016002987A (es) Biomarcadores de expresion de genes con sensibilidad a laquinimod.
PH12013500240A1 (en) Biomarker assays for detecting or measuring inhibition of tor kinase activity
PH12018550037A1 (en) Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof
IN2015DN00678A (es)
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
HK1204544A1 (en) Methods and assessment scales for measuring wrinkle severity
NZ716643A (en) Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event
WO2013160315A3 (en) Genetic predictors of response to treatment with crhr1 antagonists
IN2014DN08398A (es)
BR112015013771A2 (pt) biomarcador preditivo de resposta ao tratamento de ativador do receptor alfa 7 nicotínico de acetilcolina
MX2016002932A (es) Biomarcadores para determinacion temprana de una respueta critica o que pone la vida en peligro a la enfermedad y/o en respuesta al tratamiento.
WO2014026157A3 (en) Methionine metabolites predict aggressive cancer progression
AU334514S (en) Display package
IN2014DN08312A (es)
AU341062S (en) Measuring spoon
MX364003B (es) Tratamiento de resistencia a la insulina a traves de inhibidores del factor de transcripcion tsc22d4.
UA78641U (ru) Способ прогнозирования тяжести больных острым панкреатитом
WO2013106851A3 (en) Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes
AU341060S (en) Measuring cup
WO2014055556A3 (en) System and method for automatically generating a historical health trend graph for a patient
WO2015092444A3 (en) Biomarkers
AU2013366242A8 (en) Signature predictive of the biomineralization capacity of a graft-donor pearl oyster